A detailed history of New York State Common Retirement Fund transactions in Bio Techne Corp stock. As of the latest transaction made, New York State Common Retirement Fund holds 669,284 shares of TECH stock, worth $52.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
669,284
Previous 630,876 6.09%
Holding current value
$52.7 Million
Previous $44.4 Million 7.99%
% of portfolio
0.06%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$62.12 - $84.15 $2.39 Million - $3.23 Million
38,408 Added 6.09%
669,284 $48 Million
Q1 2024

May 07, 2024

SELL
$65.98 - $77.09 $791,891 - $925,234
-12,002 Reduced 1.87%
630,876 $44.4 Million
Q4 2023

Feb 01, 2024

BUY
$52.83 - $78.22 $1.41 Million - $2.09 Million
26,724 Added 4.34%
642,878 $49.6 Million
Q3 2023

Nov 07, 2023

SELL
$67.52 - $89.42 $1.62 Million - $2.15 Million
-24,053 Reduced 3.76%
616,154 $41.9 Million
Q2 2023

Aug 07, 2023

SELL
$73.76 - $85.98 $426,406 - $497,050
-5,781 Reduced 0.89%
640,207 $52.3 Million
Q1 2023

May 18, 2023

BUY
$71.62 - $86.62 $57,296 - $69,296
800 Added 0.12%
645,988 $47.9 Million
Q1 2023

May 02, 2023

SELL
$71.62 - $86.62 $451,206 - $545,706
-6,300 Reduced 0.97%
645,188 $47.9 Million
Q4 2022

Jan 30, 2023

BUY
$80.67 - $352.29 $40.5 Million - $177 Million
502,014 Added 335.85%
651,488 $54 Million
Q3 2022

Nov 08, 2022

SELL
$282.54 - $391.85 $228,009 - $316,222
-807 Reduced 0.54%
149,474 $42.5 Million
Q2 2022

Aug 04, 2022

SELL
$322.67 - $449.65 $7.44 Million - $10.4 Million
-23,063 Reduced 13.3%
150,281 $52.1 Million
Q1 2022

May 05, 2022

BUY
$353.85 - $487.79 $573,237 - $790,219
1,620 Added 0.94%
173,344 $75.1 Million
Q4 2021

Feb 02, 2022

SELL
$456.15 - $525.06 $1.01 Million - $1.17 Million
-2,225 Reduced 1.28%
171,724 $88.8 Million
Q3 2021

Nov 02, 2021

SELL
$444.87 - $538.88 $33.9 Million - $41 Million
-76,155 Reduced 30.45%
173,949 $84.3 Million
Q2 2021

Aug 02, 2021

SELL
$387.35 - $450.26 $6.35 Million - $7.39 Million
-16,402 Reduced 6.15%
250,104 $113 Million
Q1 2021

May 11, 2021

SELL
$314.62 - $411.0 $7.41 Million - $9.68 Million
-23,560 Reduced 8.12%
266,506 $102 Million
Q4 2020

Feb 08, 2021

SELL
$246.9 - $321.87 $1.58 Million - $2.06 Million
-6,400 Reduced 2.16%
290,066 $92.1 Million
Q3 2020

Nov 05, 2020

SELL
$232.22 - $282.96 $1.89 Million - $2.31 Million
-8,155 Reduced 2.68%
296,466 $73.4 Million
Q2 2020

Aug 07, 2020

SELL
$185.43 - $279.56 $2.57 Million - $3.87 Million
-13,855 Reduced 4.35%
304,621 $80.4 Million
Q1 2020

May 06, 2020

SELL
$161.17 - $221.51 $129,580 - $178,094
-804 Reduced 0.25%
318,476 $60.4 Million
Q4 2019

Feb 05, 2020

SELL
$189.68 - $222.09 $1.75 Million - $2.05 Million
-9,250 Reduced 2.82%
319,280 $70.1 Million
Q3 2019

Nov 07, 2019

SELL
$183.56 - $216.72 $3.12 Million - $3.68 Million
-16,980 Reduced 4.91%
328,530 $64.3 Million
Q2 2019

Aug 09, 2019

SELL
$188.72 - $215.43 $1.25 Million - $1.43 Million
-6,646 Reduced 1.89%
345,510 $72 Million
Q1 2019

May 08, 2019

BUY
$136.09 - $200.44 $122,481 - $180,396
900 Added 0.26%
352,156 $69.9 Million
Q4 2018

Feb 08, 2019

SELL
$132.75 - $203.8 $4.68 Million - $7.18 Million
-35,225 Reduced 9.11%
351,256 $50.8 Million
Q3 2018

Nov 07, 2018

BUY
$147.44 - $204.11 $88,464 - $122,466
600 Added 0.16%
386,481 $78.9 Million
Q2 2018

Aug 10, 2018

SELL
$144.9 - $165.58 $1.97 Million - $2.25 Million
-13,600 Reduced 3.4%
385,881 $57.1 Million
Q1 2018

May 10, 2018

SELL
$131.46 - $151.04 $9.37 Million - $10.8 Million
-71,258 Reduced 15.14%
399,481 $60.3 Million
Q4 2017

Feb 13, 2018

SELL
$121.17 - $134.75 $24,234 - $26,950
-200 Reduced 0.04%
470,739 $61 Million
Q3 2017

Nov 06, 2017

SELL
$113.59 - $123.78 $658,822 - $717,924
-5,800 Reduced 1.22%
470,939 $56.9 Million
Q2 2017

Aug 11, 2017

BUY
N/A
476,739
476,739 $56 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3.09B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.